tiprankstipranks
Tempest Therapeutics (TPST)
NASDAQ:TPST
US Market

Tempest Therapeutics (TPST) Income Statement

Compare
1,225 Followers

Tempest Therapeutics Income Statement

Last quarter (Q3 2024), Tempest Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Tempest Therapeutics's net income was $-10.56M. See Tempest Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -381.00K$ -1.81M$ -1.27M$ -815.00K$ -1.05M
Operating Expenses
$ 29.16M$ 34.64M$ 26.99M$ 19.30M$ 44.35M
Depreciation and Amortization
$ 381.00K$ 1.81M$ 1.27M$ 815.00K$ 1.05M
EBITDA
$ -28.78M$ -32.28M$ -25.72M$ -18.39M$ -43.52M
Operating Income
$ -29.16M$ -34.64M$ -26.99M$ -19.30M$ -45.40M
Other Income/Expenses
$ -334.00K$ -1.07M$ -1.32M$ 90.00K$ -21.19M
Pretax Income
$ -29.49M$ -35.71M$ -28.30M$ -19.21M$ -44.57M
Net Income
$ -29.49M$ -36.78M$ -29.55M$ -19.12M$ -44.57M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.91$ -3.18$ -7.80$ -612.56$ -48.77
Diluted EPS
$ -1.91$ -3.18$ -7.80$ -612.56$ -48.77
Weighted Average Shares Outstanding
15.42M 11.55M 3.79M 31.21K 913.78K
Weighted Average Shares Outstanding (Diluted)
15.42M 11.55M 3.79M 31.21K 913.78K
Currency in USD

Tempest Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis